Shanghai MicroPort Endovascular MedTech Co., Ltd. provided earnings guidance for the year 2019. The company predicts that the net profit belonging to shareholders of the company in 2019 will be between RMB 131,439,500 and RMB 149,569,000. The net profit belonging to shareholders of the company after excluding extraordinary profit and loss will be between RMB 113,020,100 and RMB 129,763,800.